| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +83.33% | +2.34% | +1.09% | +1.25% | +8.13% | — |
| 14d | 6 | +33.33% | -3.71% | -2.60% | -1.11% | -4.26% | — |
| 30d | 6 | +33.33% | +18.89% | -3.22% | +22.11% | -1.21% | — |
| 60d | 6 | +66.67% | +24.42% | -0.15% | +24.57% | +23.57% | — |
| 90d | 6 | +100.00% | +1.53% | -0.34% | +1.87% | +8.52% | — |
| 180d | 6 | +100.00% | +68.23% | +5.45% | +62.78% | +78.77% | — |
| 1y | 6 | +66.67% | -7.97% | +16.12% | -24.09% | -16.23% | — |
| 2y | 6(1 pending) | +20.00% | -36.26% | +44.48% | -80.73% | -66.23% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 125,000 | — | — | 125,000 | Apr 9, 2025 | Sep 10, 2025 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE Chairman and Chief Scientist | 40,000 | $1.17 | $46.8K | 84,634 | Dec 17, 2024 | Dec 17, 2024 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE Chief Scientist | 100,000 | $0.33 | $33.0K | 446,332 | Aug 23, 2023 | Aug 24, 2023 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE Chief Scientist | 200,000 | $0.32 | $64.4K | 346,332 | Aug 22, 2023 | Aug 22, 2023 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | SALE | 400,000 | $1.00 | $400.0K | 12,899,997 | Dec 7, 2022 | Dec 9, 2022 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE Chief Scientist | 100,000 | $58.00 | $5.80M | 146,332 | Jun 1, 2022 | Jun 2, 2022 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASE Chief Scientist | 100,000 | $0.58 | $58.0K | 146,332 | Jun 1, 2022 | Jun 2, 2022 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 46,332 | — | — | 46,332 | May 24, 2021 | Jun 10, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,422,000 | — | — | 1,422,000 | May 24, 2021 | Jun 10, 2021 ↗ | View → |
| NRXP NRX PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 13,348,997 | — | — | 13,348,997 | May 24, 2021 | Jun 10, 2021 ↗ | View → |